Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio

K-Number: K242706 · 2025-05-16

Decision Date2025-05-16
Product CodeSET
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is a medical device manufactured by Fujirebio Diagnostics,Inc.. It received FDA 510(k) clearance on 2025-05-16 under approval number K242706. The device is classified under product code SET. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio?

Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is a medical device that received FDA 510(k) clearance on 2025-05-16. It is manufactured by Fujirebio Diagnostics,Inc.. The 510(k) number is K242706.

When was Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio approved by the FDA?

Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio received FDA 510(k) clearance on 2025-05-16, under approval number K242706.

What company makes Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio?

Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is manufactured by Fujirebio Diagnostics,Inc..

What is the FDA product code for Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio?

The FDA product code for Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is SET.

Related Clinical Trials

Other Devices by Fujirebio Diagnostics,Inc.

View all 18 devices →

Related Devices (Code: SET)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.